Clinical Trial


Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)


Brief description

The main objectives of this large phase IIb/III paediatric study are to assess the efficacy and safety of dabigatran etexilate relative to standard of care and to document the appropriateness of the proposed dabigatran etexilate dosing algorithm for use in patients from birth to less than 18 years of age.

Keywords

  •   Venous Thromboembolism

Sponsored By

Boehringer Ingelheim

Unique Study ID

NCT01895777

Investigators and Research Sites Near You - Found( 3 )

No Investigator Listed

Takeda
95815, Sacramento, California, United States
Distance from Current Trial is 0 miles

No Investigator Listed

National Cancer Institute (NCI)
95817, Sacramento, California, United States
Distance from Current Trial is 0 miles

No Investigator Listed

AstraZeneca
95819-3957, Sacramento, California, United States
Distance from Current Trial is 0 miles
View All